GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » National Health Investors Inc (NYSE:NHI) » Definitions » Peter Lynch Fair Value

National Health Investors (National Health Investors) Peter Lynch Fair Value

: N/A (As of Today)
View and export this data going back to 1991. Start your Free Trial

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for National Health Investors's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of National Health Investors was 2.11. The lowest was 0.93. And the median was 1.15.


NHI's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the REITs industry.
Industry Median: 1.2
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


National Health Investors Peter Lynch Fair Value Historical Data

The historical data trend for National Health Investors's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Health Investors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

National Health Investors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the REIT - Healthcare Facilities subindustry, National Health Investors's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Health Investors Price-to-Peter-Lynch-Fair-Value Distribution

For the REITs industry and Real Estate sector, National Health Investors's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where National Health Investors's Price-to-Peter-Lynch-Fair-Value falls into.



National Health Investors Peter Lynch Fair Value Calculation

National Health Investors's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *2.893
=N/A

National Health Investors's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.89.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


National Health Investors  (NYSE:NHI) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

National Health Investors's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=60.44/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Health Investors Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of National Health Investors's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


National Health Investors (National Health Investors) Business Description

Traded in Other Exchanges
Address
222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a housing and medical facility REIT. The company operate through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. Real Estate Investments segment consists of real estate investments and lease, mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. SHOP segment is comprised of two ventures that own the operations of independent living facilities. Company's revenues are derived from rental income, mortgage and other notes receivable interest income and resident fees and services.
Executives
James R Jobe director 707 REGAL DRIVE, MURFREESBORO TN 37129
Robert G Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Colden Tracy M J director C/O PLAYA HOTELS & RESORTS N.V.,, 3950 UNIVERSITY DRIVE, SUITE 301, FAIRFAX VA 22030
Robert T Webb director PO BOX 1102, MURFREESBORO TN 37133-1102
D. Eric Mendelsohn officer: EVP - Corporate Finance C/O EMERITUS CORPORATION, 3131 ELLIOTT AVENUE, SUITE 500, SEATTLE WA 98121
Mccabe Robert A Jr director 500 CHURCH ST, STE 200, NASHVILLE TN 37219
David L Travis officer: SVP/Chief Accounting Officer C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
W Andrew Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Kevin Carlton Pascoe officer: EVP - Investments 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Ronald V Reel officer: Chief Accounting Officer 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Kristin Sallee Gaines officer: Chief Credit Officer 2320 LONDONDERRY DRIVE, MURFREESBORO TN 37129
John L Spaid officer: Exec. VP of Finance 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Roger R Hopkins officer: Chief Accounting Officer 2930 PRINCETON LANE, MURFREESBORO TN 37129
James Justin Hutchens officer: President and COO C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Ted H Welch director PO BOX 1102, MURFREESBORO TN 37133-1102

National Health Investors (National Health Investors) Headlines